By directly measuring functional mitochondrial activity rather than relying solely on static genetic markers, dynamic BH3 profiling may facilitate stratification of TP53 mutant AML patients based on real-time dependencies on anti-apoptotic proteins. Here, TP53 is linked to acute myeloid leukemia.